Jump to content

Template:Further points for assessing the study: Difference between revisions

From CAMIH
No edit summary
No edit summary
Line 12: Line 12:
|-
|-
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis  
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis  
| style="text-align:center; white-space: pre-wrap;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]]
| style="text-align:center;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]]
|-
|-
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm)
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm)
Line 27: Line 27:
|-
|-
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects  
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects  
| style="white-space: pre-wrap;" | [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects  
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects  
| style="white-space: pre-wrap;" | [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Other reasons  
! style="text-align:left; text-indent:3em;" | - Other reasons  
| style="white-space: pre-wrap;" | [[Other reasons::{{{Other reasons|}}}]]
| [[Other reasons::{{{Other reasons|}}}]]
|}
|}
==Statistics==
==Statistics==

Revision as of 12:08, 28 August 2024

This is the "Further points for assessing the study" template.

It should be called in the following format:

{{Further points for assessing the study
|Samples sufficiently large=
|power analysis performed=
|reasons given for samples=
|Ethnicity mentioned=
|Possibility of attention effects=
|Possibility of placebo effects=
|Other reasons=
|Testing for normal distribution=
|Correct application of statistical=
|Correction for multiple testing=
|Measurement of compliance=
|Blinding reliable=
|Check whether blinding was successful=
|Consistent reporting in numbers=
|Sufficient washout period=
|Tested for carry-over=
|Were sequence effects tested=
|Comprehensive and coherent reporting=
|Were side effects systematically recorded=
|Effect sizes reported=
|Side effects taken into account in the interpretation of the results=
|mono- or multicentric=
|Ethics / CoI / Funding=
}}

Edit the page to see the template text.